Glutathione deficit during development induces anomalies in the rat anterior cingulate GABAergic neurons: Relevance to schizophrenia

Neurobiology of Disease

Volumn 22, Issue 3, 2006, Pages 624-637

  Cabungcal, Jan Harry ^a,b   Nicolas, Dominique ^b   Kraftsik, Rudolf ^b   Cuénod, Michel ^a   Do, Kim Q ^a   Hornung, Jean Pierre ^b  

^a DEPT UNIV DE PSYCHIATRIE ADULTE   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

amino butyric acid; Animal model; Anterior cingulate cortex; GBR 12909; Glutathione; Inhibitory interneurons; l buthionine (S,R) sulfoximine (BSO); Oxidative stress; Parvalbumin immunoreactive; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CALBINDIN; CALCIUM BINDING PROTEIN; CALRETININ; DOPAMINE; GLUTATHIONE; PARVALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; BRAIN NERVE CELL; BRAIN SLICE; CELL POPULATION; CINGULATE GYRUS; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DOPAMINE BRAIN LEVEL; EXPERIMENTAL MODEL; FEMALE; IMMUNOREACTIVITY; INTERNEURON; MALE; NEWBORN; NONHUMAN; OXIDATION REDUCTION REACTION; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SCHIZOPHRENIA;

ANIMALS; BRAIN CHEMISTRY; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; DISEASE MODELS, ANIMAL; DOPAMINE; EXTRACELLULAR FLUID; GAMMA-AMINOBUTYRIC ACID; GLUTATHIONE; IMMUNOHISTOCHEMISTRY; MALE; NEURONS; PARVALBUMINS; PREFRONTAL CORTEX; RATS; SCHIZOPHRENIA;

EID: 33744802393     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2006.01.003     Document Type: Article

References (113)

1. Ahmed B., Anderson J.C., Martin K.A.C., and Nelson J.C. Map of the synapses onto layer 4 basket cells of the primary visual cortex of the cat. J. Comp. Neurol. 380 (1997) 230-242
2. Akbarian S., Kim J.J., Potkin S.G., Hagman J.O., Tafazzoli A., Bunney Jr. W.E., and Jones E.G. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch. Gen. Psychiatry 52 (1995) 258-566
3. Alcantara S., Ferrer I., and Soriano E. Postnatal development of parvalbumin and calbindin D28K immunoreactivities in the cerebral cortex of the rat. Anat. Embryol. 188 (1993) 63-73
4. Altar C.A., Jurata L.W., Charles V., Lemire A., Liu P., Bukhman Y., Young T.A., Bullard J., Yokoe H., Webster M.J., Knable M.B., and Brockman J.A. Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol. Psychiatry 58 (2005) 85-96
5. Amato A., Connolly C.N., Moss S.J., and Smart T.G. Modulation of neuronal and recombinant GABAA receptors by redox reagents. J. Physiol. 517 (1999) 35-50
6. Andreasen N.C. Schizophrenia: the fundamental questions. Brain Res. Brain Res. Rev. 31 (2000) 106-112
7. Bartlett E.L., Stark J.M., Guillery R.W., and Smith P.H. Comparison of the fine structure of cortical and collicular terminals in the rat medial geniculate body. Neuroscience 100 (2000) 811-828
8. Beasley C.L., and Reynolds G.P. Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics. Schizophr. Res. 24 (1997) 349-355
9. Beasley C.L., Zhang Z.J., Patten I., and Reynolds G.P. Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins. Biol. Psychiatry 52 (2002) 708-715
10. Benes F.M., McSparren J., Bird E.D., SanGiovanni J.P., and Vincent S.L. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch. Gen. Psychiatry 48 (1991) 996-1001
11. Breier A., Su T.P., Saunders R., Carson R.E., Kolachana B.S., de Bartlosomeis A., Weinberger D.R., Weisenfeld N., Malhotra A.K., Eckelman W.C., and Pickar D. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 2569-2574
12. Cabungcal J.H., Singer D., Hornung J.-P., Cuénod M., Do K.Q., and Schenk F. Spatial bias deficit in rats with low glutathione during development: a behavior model with relevance to schizophrenia. Schizophr. Res. 67 1 (2004) 118
13. Cabungcal J.H., Hornung J.-P., Cuénod M., Do K.Q., and Schenk F. Impaired place discrimination in adult rats with low cerebral glutathione during brain development: an animal behavior model with relevance to schizophrenia. Abstr. Soc. Neurosci. 797 (2004) 13
14. Carder R.K., Leclerc S.S., and Hendry S.H. Regulation of calcium-binding protein immunoreactivity in GABA neurons of macaque primary visual cortex. Cereb. Cortex 6 (1996) 271-287
15. Carlsson A., Waters N., Holm-Waters S., Tedroff J., Nilsson M., and Carlsson M.L. Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 237-260
16. Castagné V., Gautschi M., Lefèvre K., Posada A., and Clarke P.G.H. Relationships between neuronal death and the cellular redox status. Focus on the developing nervous system. Prog. Neurobiol. 59 (1999) 397-423
17. Castagné V., Cuénod M., and Do K.Q. An animal model with relevance to schizophrenia: sex-dependent cognitive deficits in Osteogenic disorder-Shionogi rats induced by glutathione synthesis and dopamine uptake inhibition during development. Neuroscience 123 (2004) 821-834
18. Cauli B., Audinat E., Lambolez B., Angulo M.C., Ropert N., Tsuzuki K., Hestrin S., and Rossier J. Molecular and physiological diversity of cortical nonpyramidal cells. J. Neurosci. 10 (1997) 3894-3906
19. Cellerino A., Siciliano R., Domenici L., and Maffei L. Parvalbumin immunoreactivity: a reliable marker for the effects of monocular deprivation in the rat visual cortex. Neuroscience 51 (1993) 749-753
20. Chan S.W., and Reade P.C. Determination of the l-ascorbic acid requirements in Osteogenic disorder Shionogi rats for prolonged carcinogenesis experiments. Lab. Anim. 30 (1996) 337-346
21. Choi Y.B., and Lipton S.A. Redox modulation of the NMDA receptor. Cell. Mol. Life Sci. 57 (2000) 1535-1541
22. Cochran S.M., Kennedy M., McKerchar C.E., Steward L.J., Pratt J.A., and Morris B.J. Induction of metabolic hypofunction and neurochemical deficit after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs. Neuropsychopharmacology 28 (2003) 265-275
23. Conde F., Lund J.S., Jacobowitz D.M., Baimbridge K.G., and Lewis D.A. Local circuit neurons immunoreactive for calretinin, calbindin D-28k or parvalbumin in monkey prefrontal cortex: distribution and morphology. J. Comp. Neurol. 341 (1994) 95-116
24. Corfas G., Roy K., and Buxbaum J.D. Neuregulin 1-erbB signal and the molecular/cellular basis of schizophrenia. Nat. Neurosci. 7 (2004) 575-580
25. Coyle J.T., and Tsai G. NMDA receptor function, neuroplasticity, and the pathophysiology of schizophrenia. Int. Rev. Neurobiol. 59 (2004) 491-515
26. DeFelipe J. Types of neurons, synaptic connections and chemical characteristics of cell immunoreactive for calbindin-D28K, parvalbumin and calretinin in the neocortex. J. Chem. Neuroanat. 14 (1997) 1-19
27. DeFelipe J., and Jones E.G. Parvalbumin immunoreactivity reveals layer IV of monkey cerebral cortex as a mosaic of microzones of thalamic afferent terminations. Brain Res. 562 (1991) 39-47
28. DeFelipe J., Hendry S.H., and Jones E.G. Visualization of chandelier cell axons by parvalbumin immunoreactivity in monkey cerebral cortex. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 2093-2097
29. DeFelipe J., Hendry S.H., and Jones E.G. Synapses of double bouquet cells in monkey cerebral cortex visualized by calbindin immunoreactivity. Brain Res. 503 (1989) 49-54
30. de Lima A.D., and Morrison J.H. Ultrastructural analysis of somatostatin-immunoreactive neurons and synapses in the temporal and occipital cortex of the macaque monkey. J. Comp. Neurol. 283 (1989) 212-227
31. del Rio M.R., and DeFelipe J. A light and electron microscopic study of calbindin D-28K immunoreactive double bouquet cells in the human temporal cortex. Brain Res. 690 (1995) 133-140
32. Do K.Q., Lauer C.J., Schreiber W., Zollinger M., Gutteck-Amsler U., Cuénod M., and Holsboer F. gamma-Glutamylglutamine and taurine concentrations are decreased in the cerebrospinal fluid of drug-naive patients with schizophrenic disorders. J. Neurochem. 65 (1995) 2652-2662
33. Do K.Q., Trabesinger A.H., Kirsten-Krüger M., Lauer C.J., Dydak U., Hell D., Holsboer F., Boesiger P., and Cuénod M. Schizophrenia: glutathione deficit in cerebro spinal fluid and prefrontal cortex in vivo. Eur. J. Neurosci. 12 (2000) 3721-3728
34. Do K.Q., Bovet P., Cabungcal J., Castagné V., Gheorghita F., Hornung J.-P., Schenk F., Steullet P., Tosic M., and Cuénod M. Glutathione deficit in schizophrenia: a new vulnerability factor for misconnectivity?. Abstr.-Soc. Neurosci. 111 (2004) 13
35. Fagiolini M., and Hensch T.K. Inhibitory threshold for critical-period activation in primary visual cortex. Nature 404 (2000) 183-186
36. Fairen A., DeFelipe J., and Regidor J. Nonpyramidal neurons. In: Peters A., and Jones E.G. (Eds). Cerebral Cortex (1982), Plenum Press, New York 201-253
37. Fonseca M., Soriano E., Ferrer I., Martinez A., and Tunon T. Chandelier cell axons identified by parvalbumin-immunoreactivity in the normal human temporal cortex and in Alzheimer's disease. Neuroscience 55 (1993) 1107-1116
38. Gabbot P.L.A., and Bacon S.J. Local circuit neurons in the medial prefrontal cortex (areas 24a, b, c, 25 and 32) in the monkey: II. Quantitative area and laminar distributions. J. Comp. Neurol. 364 (1996) 609-636
39. Garey L.J., Ong W.Y., Patel T.S., Kanani M., Davis A., Mortimer A.M., Barnes T.R., and Hirsch S.R. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J. Neurol., Neurosurg. Psychiatry 65 (1998) 446-453
40. Gibson J.R., Beierlein M., and Connors B.W. Two networks of electrically coupled inhibitory neurons in neocortex. Nature 402 (1999) 75-79
41. Glantz L.A., and Lewis D.A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry 57 (2000) 65-73
42. Grima G., Benz B., Parpura V., Cuenod M., and Do K.Q. Dopamine-induced oxidative stress in neurons with glutathione deficit: implication for schizophrenia. Schizophr. Res. 62 (2003) 213-224
43. Gupta A., Wang Y., and Markram H. Organizing principles for a diversity of GABAergic interneurons and synapses in the neocortex. Science 287 (2000) 273-278
44. Hakak Y., Walker J.R., Li C., Wong W.H., Davis K.L., Buxbaum J.D., Haroutunian V., and Fienberg A.A. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 4746-4751
45. Halliwell B. Reactive oxygen species and the central nervous system. J. Neurochem. 59 (1992) 1609-1623
46. Harrison P.J., and Owen M.J. Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet 361 (2003) 417-419
47. Harrison P.J., and Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 10 (2005) 40-68
48. Hashimoto T., Volk D.W., Eggan S.M., Mirnics K., Pierri J.N., Sun Z., Sampson A.R., and Lewis D.A. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J. Neurosci. 23 (2003) 6315-6326
49. Hendry S.H., Houser C.R., Jones E.G., and Vaughn J.E. Synaptic organization of immunocytochemically identified GABA neurons in the monkey sensory-motor cortex. J. Neurocytol. 76 (1983) 467-472
50. Hendry S.H., Jones E.G., Emson P.C., Lawson D.E., Heizmann C.W., and Streit P. Two classes of cortical GABA neurons defined by differential calcium binding protein immunoreactivities. Exp. Brain Res. 76 (1989) 467-472
51. Herken H., Uz E., Ozyurt H., Sogut S., Virit O., and Akyol O. Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia. Mol. Psychiatry 6 (2001) 66-73
52. Jacobsen J.P.R., Rodriguez R.M., Mork A., and Wetsel W.C. Monoaminergic dysregulation in glutathione-deficient mice: possible relevance to schizophrenia?. Neuroscience 132 (2005) 1055-1072
53. Jones E.G. GABAergic neurons and their role in cortical plasticity in primates. Cerebral Cortex 3 (1993) 361-372
54. Jones E.G., and Hendry S.H. Basket cells. In: Peter A., and Jones E.G. (Eds). Cerebral Cortex (1984), Plenum Press, New York 309-336
55. Kawaguchi Y., and Kubota Y. GABAergic cell subtypes and their synaptic connections in the rat frontal cortex. Cereb. Cortex 6 (1997) 476-486
56. Kohr G., Eckardt S., Luddens H., Monyer H., and Seeburg P.H. NMDA receptor channels: subunit-specific potentiation by reducing agents. Neuron 12 (1994) 1031-1040
57. Kubota Y., Hattori R., and Yui Y. Three distinct subpopulations of GABAergic neurons in rat frontal agranular cortex. Brain Res. 649 (1994) 159-173
58. Laruelle M., Abi-Dargham A., van Dyck C.H., Gil R., D'Souza C.D., Erdos J., McCance E., Rosenblatt W., Fingado C., Zoghbi S.S., Baldwin R.M., Seibyl J.P., Krystal J.H., Charney D.S., and Innis R.B. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenia subjects. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 9235-9240
59. Leuba G., Kraftsik R., and Saini K. Quantitative distribution of parvalbumin, calretinin, and calbindin D-28k immunoreactive neurons in the visual cortex of normal and Alzheimer cases. Exp. Neurol. 152 (1998) 278-291
60. Lewis D.A. GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia. Brain Res. Brain Res. Rev. 31 (2000) 270-276
61. Lewis D.A., and Levitt P. Schizophrenia as a disorder of neurodevelopment. Annu. Rev. Neurosci. 25 (2002) 409-432
62. Lewis D.A., Cruz D.A., Melchitzky D.S., and Pierri J.N. Lamina-specific deficits in parvalbumin-immunoreactive varicosities in the prefrontal cortex of subjects with schizophrenia: evidence for fewer projections from the thalamus. Am. J. Psychiatry 158 (2001) 1411-1422
63. Lipton S.A., Choi Y.B., Pan Z.H., Lei S.Z., Chen H.S., Sucher N.J., Loscalzo J., Singel D.J., and Stamler J.S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364 (1993) 626-632
64. Liu G. Local structural balance and functional interaction of excitatory and inhibitory synapses in hippocampal dendrites. Nat. Neurosci. 7 (2004) 373-379
65. Lund J.S., and Lewis D.A. Local circuit neurons of developing and mature macaque prefrontal cortex: Golgi and immunocytochemical characteristics. J. Comp. Neurol. 328 (1993) 282-312
66. Mahadik S.P., and Mukherjee S. Free radical pathology and antioxidant defense in schizophrenia: a review. Schizophr. Res. 19 (1996) 1-17
67. Marchbanks R.M., Ryan M., Day I.N., Owen M., McGuffin P., and Whatley S.A. A mitochondrial DNA sequence variant associated with schizophrenia and oxidative stress. Schizophr. Res. 65 (2003) 33-38
68. Marenco S., and Weinberger D.R. The neurodevelopmental hypothesis of schizophrenia: following a trail of evidence from cradle to grave. Dev. Psychopathol. 12 (2000) 501-527
69. Markram H., Toledo-Rodriguez M., Wang Y., Gupta A., Silberberg G., and Wu C. Interneurons of the neocortical inhibitory system. Nat. Rev., Neurosci. 10 (2004) 793-807
70. Martensson J., and Meister A. Glutathione deficiency increases hepatic ascorbic acid synthesis in adult mice. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 11566-11568
71. Massengill J.L., Smith M.A., Son D.I., and O'Dowd D.K. Differential expression of K4-AP currents and Kv3.1 potassium channel transcript in cortical neurons that develop distinct firing phenotypes. J. Neurosci. 9 (1997) 3136-3147
72. Matecka D., Rothman R.B., Radesca L., de Costa B.R., Dersch C.M., Partilla J.S., Pert A., Glowa J.R., Wojnicki F.H., and Rice K.C. Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909). J. Med. Chem. 24 (1996) 4704-4716
73. Meister A. Glutathione biosynthesis and its inhibition. Methods Enzymol. 252 (1995) 26-30
74. Meister A., and Anderson M.E. Glutathione. Annu. Rev. Biochem. 52 (1983) 711-760
75. Mirnics K., Middleton F.A., Marquez A., Lewis D.A., and Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28 (2000) 53-67
76. Moon J.S., Kim J.J., Chang I.Y., Chung Y.Y., Jun J.Y., You H.J., and Yoon S.P. Postnatal development of parvalbumin and calbindin-D28k immunoreactivities in the canine anterior cingulate cortex: transient expression in the layer V pyramidal cells. Int. J. Dev. Neurosci. 20 (2002) 511-519
77. Nanda D., Tolputt J., and Collard K.J. Changes in brain glutathione levels during postnatal development in the rat. Dev. Brain Res. 94 (1996) 238-241
78. Ohnuma T., Augood S.J., Arai H., McKenna P.J., and Emson P.C. Measurement of GABAergic parameters in the prefrontal cortex in schizophrenia: focus on GABA content, GABAA receptor alpha-1 subunit messenger RNA expression. Neuroscience 93 (1999) 441-448
79. Pan Z.H., Bahring R., Grantyn R., and Lipton S.A. Differential modulation by sulfhydryl redox agents and glutathione of GABA- and glycine-evoked currents in rat retinal ganglion cells. J. Neurosci. 15 (1995) 1384-1391
80. Parnas J., Bovet P., and Innocenti G.M. Schizophrenic trait features, binding, and cortico-cortical connectivity: a neurodevelopmental pathogenic hypothesis. Neurol. Psychiatry Brain Res. 4 (1996) 185-196
81. Peters A. Chandelier cells. In: Peter A., and Jones E.G. (Eds). Cerebral Cortex (1984), Plenum Press, New York 361-380
82. Pierri J.N., Chaundry A.S., Woo T.-U., and Lewis D.A. Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. Am. J. Psychiatry 156 (1999) 1709-1719
83. Porter L.L., Rizzo E., and Hornung J.P. Dopamine affects parvalbumin expression during cortical development in vitro. J. Neurosci. 19 (1999) 8990-9003
84. Prabakaran S., Swatton J.E., Ryan M.M., Huffaker S.J., Huang J.J., Griffin J.L., Wayland M., Freeman T., Dudbridge F., Lilley K.S., Karp N.A., Hester S., Tkachev D., Mimmack M.L., Yolken R.H., Webster M.J., Torrey E.F., and Bahn S. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol. Psychiatry 9 (2004) 684-697
85. Rabinovic A.D., and Hastings T.G. Role of endogenous glutathione in the oxidation of dopamine. J. Neurochem. 71 (1998) 2071-2078
86. Reynolds G.P., and Beasley C.L. GABAergic neuronal subtypes in the human frontal cortex-Development and deficits in schizophrenia. J. Chem. Neuroanat. 22 (2001) 95-100
87. Reynolds G.P., Zhang Z.J., and Beasley C.L. Neurochemical correlates of cortical GABAergic deficits in schizophrenia: selective losses of calcium binding protein immunoreactivity. Brain Res. Bull. 55 (2001) 579-584
88. Rougemont M., Do K.Q., and Castagné V. New model of glutathione deficit during development: effect on lipid peroxidation in the rat brain. J. Neurosci. Res. 70 (2002) 774-783
89. Schafer F.Q., and Buettner G.R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radical Biol. Med. 30 (2001) 1191-1212
90. Schwaller B., Tetko I.V., Tandon P., Silveira D.C., Vreugdenhil M., Henzi T., Potier M.-C., Celio M.R., and Villa A.E.P. Parvalbumin deficiency affects network properties resulting in increased susceptibility to epileptic seizures. Mol. Cell. Neurosci. 25 (2004) 650-663
91. Sekirnjak C., Martone M.E., Weiser M., Deerinck T., Bueno E., Rudy B., and Ellisman M. Subcellular localization of the K+ channel subunit Kv3.1b in selected rat CNS neurons. Brain Res. 766 (1997) 173-187
92. Selemon L.D., and Goldman-Rakic P.S. The reduced neurophil hypothesis: a circuit based model of schizophrenia. Biol. Psychiatry 45 (1999) 17-25
93. Selemon L.D., Rajkowska G., and Goldman-Rakic P.S. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: application of a three-dimensional, stereologic counting method. J. Comp. Neurol. 392 (1998) 402-412
94. Somogyi P., and Cowey A. Double bouquet cells. In: Peters A., and Jones E.G. (Eds). Cerebral Cortex (1984), Plenum Press, New York 337-360
95. Somogyi P., Freund T.F., and Cowey A. The axo-axonic interneuron in the cerebral cortex of the rat, cat and monkey. Neuroscience 7 (1982) 2577-2607
96. Stanwood G.D., Washington R.A., Shumsky J.S., and Levitt P. Prenatal cocaine exposure produces consistent developmental alterations in dopamine-rich regions of the cerebral cortex. Neuroscience 106 (2001) 5-14
97. Stanwood G.D., Washington R.A., and Levitt P. Identification of a sensitive period of prenatal cocaine exposure that alters the development of the anterior cingulate cortex. Cereb. Cortex 11 (2001) 430-440
98. Stefani M.R., and Moghaddam B. Transient N-methyl-d-aspartate receptor blockade in early development causes lasting cognitive deficits relevant to schizophrenia. Biol. Psychiatry 57 (2005) 433-436
99. Steullet P., Neijt H.C., Cuénod M., and Do K.Q. Decrease in brain glutathione (GSH) in schizophrenia: effects of a deficiency in GSH on synaptic transmission and plasticity. Schizophr. Res. 67 (2004) 124
100. Steullet P., Neijt H.C., Cuénod M., and Do K.Q. Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: relevance to schizophrenia. Neuroscience 3 (2006) 807-819
101. Szentagothai J., and Arbib M.A. Conceptual models of neuronal organization. Neurosci. Res. Prog. Bull. 12 (1974) 305-510
102. Tanda G., Pontieri F.E., Frau R., and Di Chiara G. Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine. Eur. J. Neurosci. 10 (1997) 2077-2085
103. Tang L.H., and Aizenman E. The modulation of N-methyl-d-aspartate receptors by redox and alkylating reagents in rat cortical neurones in vitro. J. Physiol. 465 (1993) 303-323
104. Tosic M., Bovet P., Deppen P., Gheorghita F., Preisig M., Saraga M., Solida A., Cuenod M., and Do K.Q. Schizophrenia patients show reduced expression of the glutathione related genes. Soc. Neurosci. (2004) 909
105. Tosic M., Ott J., Barral S., Bovet P., Deppen P., Georghita F., Matthey M.L., Preisig M., Saraga M., Solida A., Cuénod M., and Do K.Q. Association of glutathione related genes with the risk of schizophrenia. Soc. Neurosci. (2005) 674.19
106. Van Brederode J.F., Helliesen M.K., and Hendrickson A.E. Distribution of the calcium binding protein parvalbumin and calbindin-D28k in the sensorimotor cortex of the rat. Neuroscience 44 (1991) 157-171
107. Volk D.W., Austin M.C., Pierri J.N., Sampson A.R., and Lewis D.A. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch. Gen. Psychiatry 57 (2000) 237-245
108. Volk D.W., Pierri J.N., Fritschy J.-M., Auh S., Sampson A.R., and Lewis D.A. Reciprocal alterations in pre- and postsynaptic inhibitor marker at chandelier cell inputs to pyramidal neurons in schizophrenia. Cereb. Cortex 10 (2002) 1063-1070
109. Wang X.H., Jenkins A.O., Choi L., and Murphy E.H. Altered neuronal distribution of parvalbumin in anterior cingulate cortex of rabbits exposed in utero to cocaine. Exp. Brain Res. 112 (1996) 359-371
110. Woo T.-U., Whitehead R.E., Melchitzky D.S., and Lewis D.A. A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 5341-5346
111. Yan Y.H., Van Brederode J.F., and Hendrickson A.E. Transient co-localization of calretinin, parvalbumin, and calbindin-D28K in developing visual cortex of monkey. J. Neurocytol. 24 (1995) 825-837
112. Yang Y., Dieter M.Z., Chen Y., Shertzer H.G., Nebert D.W., and Dalton T.P. Initial characterization of the glutamate-cysteine ligase modifier subunits Gclm (-/-) knockout mouse. Novel model system for a severely compromised oxidative stress response. J. Biol. Chem. 277 (2002) 49446-49452
113. Zhang Z.J., and Reynolds G.P. A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia. Schizophr. Res. 55 (2002) 1-10